Back to search

Article

Prognostic Value of CMTM6 Expression in Breast Cancer

2025-10-07

Abstract excerpt

<title>Abstract</title> <p>Introduction CMTM6, a regulator of tumor cell PD-L1 stability via inhibiting lysosome-mediated degradation, is linked to anti-tumor immunity and tumorigenesis. However, its expression and prognostic value in breast cancer subtypes remain unclear. Methods We conducted an integrated bioinformatics analysis of CMTM6 using multiple public databases: cBioPortal for examining genetic alterati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d8a45d5d-3ee6-5e8d-be5a-eebf05c92707
DOI
10.21203/rs.3.rs-7752340/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic Value of CMTM6 Expression in Breast CancerDOI 10.21203/rs.3.rs-7752340/v1
Prognostic Implications of Pan-cancer CMTM6 Expression and Its Relationship With the Immune MicroenvironmentSemantic proximity
CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomasSemantic proximity
Single‑cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancerSemantic proximity
Unveiling promising breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental verificationSemantic proximity
Genetic identification of the m6A-related gene YTHDF3 as a putative biomarker for breast cancerSemantic proximity
Pan-Cancer Analysis Reveals the Signature of TMC Family of Genes as a Promising Biomarker for Prognosis and Immunotherapeutic ResponseSemantic proximity
Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insightsSemantic proximity
PCMT1 has Potential Prognostic Value and Promotes Cell Growth and Motility in Breast CancerSemantic proximity
Dissecting the Role of N6-Methylandenosine-Related Long Non-coding RNAs Signature in Prognosis and Immune Microenvironment of Breast CancerSemantic proximity
Upregulation of TIMM8A is correlated with prognosis and immune regulation in BCSemantic proximity
m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer MicroenvironmentSemantic proximity
Crosstalk between mitochondrial and lysosomal co-regulators defines clinical outcomes of breast cancer by integrating multi-omics and machine learningSemantic proximity
Select a neighboring publication to make it the new centre.